Studies have demonstrated that TCA has some effect in governing depression-like behavior, and these findings suggest that TCA treatment has antidepressant effects and that it mediates depression levels by mediating COX-2 levels and regulating neurotransmitters. The gene discussed is PTGS2; the disease is depressive symptom measurement.